The acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (+)-pyripyropene E (1) has been synthesized from farnesyl acetate (9 steps, 9.6% overall yield). The convergent and stereoselective route exploited a biomimetic polyene cyclization as the key transformation.
No takes yet. Share an insight, caveat, or question.
Smith et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: